Regeneron Pharmaceuticals, Inc.
Antibodies Comprising Chimeric Constant Domains
Last updated:
Abstract:
Antibodies, antigen-binding proteins and Fc-fusion proteins that comprise recombinant polypeptides containing a chimeric heavy chain constant region sequence are provided that bind to certain Fc receptors however have reduced effector functions. Methods of making constructs for expression of such chimeric Fc-containing antibodies, antigen-binding proteins and Fc-fusion proteins in cell systems, and methods of producing and isolating the chimeric Fc-containing proteins are provided.
Status:
Application
Type:
Utility
Filling date:
30 Mar 2021
Issue date:
12 Aug 2021